Montis Biosciences

Montis Biosciences is a promising biotechnology startup based in Belgium, founded in 2020 with a clear mission encapsulated in the slogan "BREAKING INTERACTIONS IN ONCOLOGY." The company is focused on targeting the interaction between perivascular macrophages and tumor vasculature to drive and sustain immune reactions against solid tumors. Founded on foundational science from the laboratories of Prof. Peter Carmeliet and Massimiliano Mazzone (VIB-KU Leuven), Montis has quickly garnered attention and backing from an international syndicate of investors. The most recent investment of €1.00M Grant, secured on 14 June 2021 from Agentschap Innoveren & Ondernemen, demonstrates the faith and support the startup has engendered within the biotech community. With an innovative approach and a clear focus on addressing unmet needs in oncology, Montis Biosciences presents an exciting opportunity for venture capital investment.